ANNE PARKER: Open Payments
NPI 1952720088 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 21 payments from 6 companies in 2025. Trend: 2023 $1,426 · 2024 $583 · 2025 $431
Food & beverage: $332Education: $99
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $132 |
| Astellas Pharma US Inc | 2 | $128 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $67 |
| ABBVIE INC. | 2 | $39 |
| MILLICENT US INC | 2 | $34 |
| Exeltis, USA Inc. | 2 | $32 |
Products named: GEMTESA, LILETTA, MYFEMBREE, INTRAROSA, SLYND, Veozah.
Industry payments across PA — which companies pay providers there.
